Mirion to Present at B. Riley Securities’ Radiopharma Day
23 February 2024 - 8:10AM
Business Wire
Mirion (NYSE: MIR) announced today that Chief Executive Officer,
Thomas Logan, will present at B. Riley Securities’ Radiopharma Day
in New York, NY. The presentation will begin at 11:30 AM ET on
Friday, March 1, 2024.
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety,
science and medicine, empowering innovations that deliver vital
protection while harnessing the transformative potential of
ionizing radiation across a diversity of end markets. The Mirion
Technologies group provides proven radiation safety technologies
that operate with precision – for essential work within R&D
labs, critical nuclear facilities, and on the front lines. The
Mirion Medical group solutions help enhance the delivery and ensure
safety in healthcare, powering the fields of Nuclear Medicine,
Radiation Therapy QA, Occupational Dosimetry, and Diagnostic
Imaging. Headquartered in Atlanta (GA – USA), Mirion employs
approximately 2,700 people and operates in 12 countries. Learn more
at mirion.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240222117651/en/
For investor inquiries, please contact: Jerry Estes
ir@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Jan 2024 to Jan 2025
